SCHEMBL5486191

SCHEMBL5486191

Nc1ccc(CC(=O)CCC(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA2 P00918 2/20 0.42
CAMK2A Q9UQM7 1/20 0.42
GABRR1 P24046 1/20 0.41
GAA P10253 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP2C19 P33261 1/20 0.41
AKR1B1 P15121 1/20 0.40
CNR2 P34972 1/20 0.40
TSHR P16473 2/20 0.39
ABCC4 O15439 1/20 0.39
LMNA P02545 1/20 0.39
PTGS1 P23219 1/20 0.39
HTT P42858 1/20 0.39
FFAR1 O14842 1/20 0.39
GFER P55789 1/20 0.39
CYP3A4 P08684 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272776 0.83 GFER (0.50) TDP1CA2CAMK2AALDH1A1CNR2
Succinic Acid SCHEMBL27434396 0.82 LMNA (0.53) TDP1L3MBTL1GABRR1GAAALDH1A1
Succinic Acid SCHEMBL6544596 0.82 LMNA (0.53) TDP1L3MBTL1GABRR1GAAALDH1A1
SCHEMBL2028391 0.82 CA2 (0.65) TDP1L3MBTL1CA2CAMK2AGAA
SCHEMBL10275399 0.82 CNR2 (0.45) TDP1CA2CAMK2AGAAALDH1A1
SCHEMBL2131696 0.81 AKR1B1 (0.62) TDP1L3MBTL1GAAALDH1A1CYP2C19
SCHEMBL39103 0.81 CA2 (0.62) TDP1CA2CAMK2AGAAALDH1A1
SCHEMBL1331730 0.81 CA2 (0.62) TDP1CA2CAMK2AGAAALDH1A1
SCHEMBL2397311 0.80 L3MBTL1 (0.66) TDP1L3MBTL1CA2CAMK2AALDH1A1
SCHEMBL11388782 0.80 CTBP2 (0.50) TDP1L3MBTL1ALDH1A1CNR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010529-A1 Nitrogenous heterocyclic compounds and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010529-A1 Nitrogenous heterocyclic compounds and medical use thereof MAPK1, NOS1, NOS2 TDP1 1340/4885L3MBTL1 3449/4885CA2 1212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.